Riskpilot← Back to searchSign inGet full accessAQUA PHARMA GROUP AS
ASActiveOrg 922654026Hovemovegen 1, 2624 LillehammerBusiness and other management consultancy activities · NACE 7020Est. 20193 employeeswww.aqua-pharma.com
Revenue 2024
NOK 159,4M
+274% vs 2023
EBITDA margin
69.9%
+19% vs 2023
Equity ratio
77.4%
Financial strength
Net profit 2024
NOK 35,1M
+172% vs 2023
| Revenue | NOK 159,4M | +274% |
| EBITDA | NOK 111,4M | +19% |
| Net profit | NOK 35,1M | +172% |
| Total assets | NOK 341,4M | +11% |
| Equity | NOK 264,4M | +2% |
| Employees | 3 | — |
Legal name
AQUA PHARMA GROUP AS
Org number
922654026
Legal form
Aksjeselskap
NACE code
7020 · Business and other management consultancy activities
Founded
23. april 2019
Share capital
NOK 21 139 900
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Salg og utvikling av produkter for parasittbehandling innen akvakultur samt investering og eierskap i selskaper med tilsvarende virksomhet.
Address
Hovemovegen 1, 2624 Lillehammer
Phone
+4761247010
Email
post@aqua-pharma.com
Website
www.aqua-pharma.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 31 530 | 31 024 | 41 524 | 42 621 | 159 362 |
| Staff expenses | −8 991 | −11 414 | −0 | −0 | −8 849 |
| EBITDA | 4 400 | −6 059 | −14 696 | 93 628 | 111 432 |
| Depreciation & amort. | −0 | −6 | −1 083 | −100 802 | −7 063 |
| EBIT | 4 400 | −6 065 | −15 780 | −7 174 | 104 369 |
| Net financials | 112 | 387 | −58 419 | −41 509 | −48 065 |
| Profit before tax | 4 512 | −5 678 | −74 199 | −48 683 | 56 305 |
| Tax | 972 | −0 | −0 | −0 | 21 165 |
| Net profit | 3 540 | −5 678 | −74 199 | −48 683 | 35 140 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 483 878 | 474 177 | 380 817 | 307 188 | 341 406 |
| Equity | 424 872 | 389 194 | 284 996 | 259 251 | 264 391 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 59 006 | 84 983 | 95 821 | 47 937 | 77 015 |
| Total debt | 59 006 | 84 983 | 95 821 | 47 937 | 77 015 |
EBITDA margin
69.9%
This company
15.8%
Market median
+342% vs market
20202024
Equity ratio
77.4%
This company
38.2%
Market median
+103% vs market
20202024
Return on equity
13.3%
This company
18.4%
Market median
+28% vs market
20202024
Net profit margin
22.1%
This company
8.1%
Market median
+173% vs market
20202024
Asset turnover
0.47×
This company
1.12×
Market median
-58% vs market
20202024
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ER Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (1) | ||
AK Deputy Member | Deputy Member | 2020 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Chairman | 2024 | |
| Board of Directors | 2026 | |
| Board of Directors | 2026 | |
| Former (2) | ||
| Board of Directors | 2020 – 2024 | |
| Board of Directors | 2020 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2024 | |
Solvay Chemicals And Plastics Holdi | Company | 50% | 50% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AQUA PHARMA GROUP AS 
AQUA PHARMA ASBoard members of AQUA PHARMA GROUP AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arne Knutson Wråli | Deputy Member | 0 companies |
| Elvin Ronald Bugge | Chief Executive Officer | 0 companies |
| Tor Kolden | Board of Directors | 0 companies |
| Carlos Eduardo Da Silveira | Board of Directors | 0 companies |
| Eirik Bugge | Board of Directors | 0 companies |
| Marco Giannuzzi | Chairman | 0 companies |
| Alain Marie C Jeanmart | Board of Directors | 0 companies |
| Ines Hurtado Dominguez | Board of Directors | 0 companies |
| Heidi Camilla Sagen-Ohren | Board of Directors | 0 companies |
| Beatrice Francoise Marie Leroy | Board of Directors | 0 companies |